Therapy Areas: Devices
GrayMatters Health names new chief commercial officer
19 October 2023 -

GrayMatters Health (GMH), an Israel-based company that develops digital self-neuromodulation therapies for mental health care, announced on Wednesday that it has named Kirk Thelander as its new chief commercial officer.

In the new role, Thelander will be responsible for developing and implementing commercial strategies aimed at expediting growth.

Thelander has over 17 years of experience in medical device sales and management, launching mental health technologies and bringing digital therapeutics to new markets. He has previously served in leadership roles at AloeMD, LLC, Greenbrook TMS NeuroHealth Centers, Freespira and Neuronetics, Inc.